Navigation Links
Memorial University Medical Center (MUMC) Implements PNA FISH(R) Tests to Help Provide Best Care for Patients with Bloodstream Infections
Date:6/2/2009

First hospital in Georgia to use a new, cutting edge diagnostic technology to fight serious infections and improve patient care and outcomes.

WOBURN, Mass., and VEDBAEK, Denmark, June 2 /PRNewswire/ -- AdvanDx today announced Memorial University Medical Center in Savannah, Georgia has implemented AdvanDx's PNA FISH(R) tests to identify bloodstream pathogens 1 to 3 days earlier than conventional methods to help their physicians, pharmacists and nurses improve care and outcomes for patients with bloodstream infections(1).

Every year, 350,000 patients contract bloodstream infections in the United States causing over 90,000 deaths and significant costs to the healthcare system. Rapid and accurate identification of the causative pathogen is crucial to ensuring appropriate antibiotic therapy and improving patient outcomes. Conventional diagnostic methods can take 48 hours or longer forcing physicians to treat patients empirically with broad-spectrum antibiotics that may prove to be ineffective and can lead to long-term resistance.

AdvanDx's PNA FISH tests employ unique technology that detects bacteria's genetic material to provide identification results in just over 2 hours. "The fast tests will enable the microbiology lab to provide results 1 to 3 days sooner than conventional methods for such serious pathogens as Staphylococcus aureus, Candida albicans and Candida glabrata," said Vera Pagan, Microbiology Manager at Memorial University Medical Center.

Clinical trials conducted at hospitals in the United States have shown that implementing PNA FISH and delivering fast results to clinicians directed earlier, effective antibiotic therapy, reduced mortality rates and improved hospital operational efficiency by reducing hospital length of stay, bed utilization, and pharmacy and lab costs related to unnecessary antibiotic use(1,2,3). Memorial University Medical Center is the first hospital in southeast Georgia to implement the rapid PNA FISH tests.

"We are very excited to implement the latest diagnostic tool to help our clinicians identify these serious infections in our critically ill patients," said. Richard S. Roth, M.D., infectious disease physician at Savannah Infectious Disease, who along with Jason Lin, Pharm.D., Clinical Infectious Diseases Pharmacist at Memorial University Medical Center are championing the clinical implementation of using rapid microbiology results to guide therapy. "The fast results from the laboratory will enable our clinicians to know which pathogens they are dealing with much earlier, will help them prescribe the most appropriate antibiotic, and allow us to deliver the best care for our patients," Dr. Roth added.

About Memorial Health

Memorial Health is a two-state healthcare organization serving a 35-county area in southeast Georgia and southern South Carolina. The system includes its flagship hospital, a 530-bed academic medical center; Memorial primary and specialty care physician networks; a major medical education program; business and industry services; and NurseOne, a 24-hour call center.

About Bloodstream Infections

Every year, 350,000 patients contract bloodstream infections, causing over 90,000 unnecessary deaths and significant costs to the healthcare system. The infection is detected when a culture of the patient's blood (i.e. a blood culture) turns positive with bacteria and yeast. Rapid and accurate identification of the specific infecting pathogen is crucial to ensure early and appropriate therapy and save patient lives.

About PNA FISH(R)

PNA FISH is an easy-to-use and highly sensitive and specific fluorescence in situ hybridization (FISH) assay that uses PNA (peptide nucleic acid) probes to target species specific ribosomal RNA (rRNA) in live bacteria and yeast. PNA FISH tests enable microbiology labs to provide rapid and accurate identification of bloodstream pathogens directly from positive blood cultures in hours instead of days. Clinical studies show that rapid identification of bloodstream pathogens using PNA FISH tests leads to more appropriate patient therapy that saves lives and reduces unnecessary antibiotic use, patient length of stay and hospital costs.

    References:
    (1)Forrest et al.  Antimicrob Agents Chemother. 2008 Oct;52(10):3558-63.
    (2) Shoham et al. Ther Clin Risk Manag. 2008 Jun;4(3):637-40.
    (3) Forrest et al. J Antimicrob Chemother. 2006 Jul;58(1):154-8.

PN1626A


'/>"/>
SOURCE AdvanDx
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. William W. Wirtz Allocates $19.5 Million to Northwestern Memorial for Cancer Care and Research
2. The Healthcare Scoop Encourages Sun Safety This Memorial Day Weekend And Into Summer
3. Franklin Memorial Hospital Thrives on the InstaMed Network
4. Top 10 Pet Travel Tips for Memorial Day
5. Haiti Hosts Opening Ceremony of the 2009 International AIDS Candlelight Memorial: Worldwide Events Commence With the Announcement of a National HIV Testing Campaign in Haiti
6. Full Calendar of Activities for 24th Los Angeles Marathon This Memorial Day Weekend
7. Thomson Reuters Honors Keystone Mercy and AmeriHealth Mercy Health Plans and Tallahassee Memorial HealthCare
8. Dunwoody Partners with North Memorial for Radiologic Technologist Program
9. MedGenix Financial Information System Selected by Bates County Memorial Hospital
10. YWCA USA Celebrates Sojourner Truth Memorial in U.S. Capitol
11. Smallest full support heart assist device on trial at Northwestern Memorial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... ... February 23, 2017 , ... ... a clinician-based audience, will be participating in Rare Disease Day events, hosted by ... In addition, Rare Disease Report, a website, weekly e-newsletter and quarterly publication, will ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... leadership , media relations, content marketing, social media management, corporate communications, SEO and ... in the state and in nearby New Hampshire, Massachusetts and Canada, Rosica will ...
(Date:2/23/2017)... ... February 23, 2017 , ... Pink Pig Publishing LLC announces ... and explore the world from different perspectives. By providing a place for people ... understanding, increase empathy, and find greater happiness. , "Our approach to structuring ...
(Date:2/23/2017)... ... February 23, 2017 , ... The Center for Autism and ... for Autism Research and Treatment (RI-CART) and Cinemaworld to present Sensory Friendly Films. ... to see films in an environment that accommodates their unique needs. , Launched ...
(Date:2/23/2017)... ... February 23, 2017 , ... Curemark, LLC announced today that the Blüm ... in children aged 3-8 with Autism, is now enrolling at three new sites. These ... the United States. , “There are currently no approved drugs that address the ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... NEW YORK , Feb. 23, 2017 Report ... The report provides separate comprehensive analytics for the US, ... Europe , Asia-Pacific , ... estimates and forecasts are provided for the period 2015 through ... markets. Market data and analytics are derived from primary and ...
(Date:2/24/2017)... Australia , Feb. 23, 2017  Directors from Pharma To ... two companies have joined forces, resulting in the founding of Pharma ... Pharma To Market are pleased to announce their expansion ... office in Singapore . The company are delighted ... as Co-Director of the Singapore based entity. ...
(Date:2/24/2017)... NEW YORK , Feb. 23, 2017 /PRNewswire/ ... USD 330.6 million by 2021 from USD 275.9 ... Read the full report: http://www.reportlinker.com/p04718602-summary/view-report.html ... industries, increasing spending on pharmaceutical R&D, and growth ... factors driving the market growth for particle counters. ...
Breaking Medicine Technology: